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INTRODUCTION
Viral upper and lower respiratory tract infection (LRTI) is one of the most common infections among humans and is the main cause of mortality of children up to five years of age (Berry et al., 2015) . Viruses more commonly associated with aetiology of LRTI are respiratory syncytial virus, influenza virus types A and B, parainfluenza types 1, 2 and 3, and adenovirus types 1-5, 7, 14, 19 and 37 (Henrickson et al., 2004; Mahony, 2008; Nichols et al., 2008; Pavia, 2011) . In the begining of the 21 st century, several new viruses associated with respiratory tract infections were discovered.
These are metapneumovirus, coronaviruses NL63 and HKU1, parainfluenza virus type 4 and human bocavirus 1 (HBoV1) (Pavia, 2011) . In the case of respiratory tract diseases, simultaneous infection of more than one respiratory virus is often detected (Pinky and Dobrovolny, 2016) . Unfortunately, it is not possible to determine the exact aetiological agent based on clinical signs only (Pavia, 2011) .
HBoV1, which belongs to the Parvoviridae family, Parvovirinae subfamily, Bocaparvovirus genus, was discovered in 2005 in airway specimens of patients with respiratory diseases (Allander et al., 2005) . Since then it has been found worldwide throughout the year in about 2 to 20% of airway samples of symptomatic as well as asymptomatic individuals, mainly aged from six months to five years, with upper respiratory tract infection or LRTI (Jartti et al., 2012; Qiu et al., 2016.) . HBoV1 is considered as the fourth most prevalent respiratory virus in the world (Tabasi et al., 2016) . Currently three more HBoVs are known -HBoV2, HBoV3, and HBoV4. These viruses were discovered in stool samples of patients with gastroenteritis (Kapoor et al., 2009; Arthur et al., 2009; Kapoor et al., 2010) and are not considered as respiratory pathogens.
Respiratory tract diseases are a serious problem also in the children population of Latvia. According to data from the Disease Prevention and Control Centre of Latvia, respiratory tract diseases are the major reason of morbidity for children under one year of age.
This is the first study in Latvia reflecting the presence of HBoV1 and 18 other respiratory viruses in airway samples of pediatric patients with LRTI.
The aim of this study was to determine the presence of HBoV1 and its co-infection with 18 other respiratory viruses in nasopharyngeal aspirates (NPA) of children with LRTI in Latvia.
MATERIALS AND METHODS
Patients and sample collection. The study was conducted in accordance with safety standards, the study protocol was approved by the Ethics Committee of Rîga Stradiòð University on 30 May 2013 (permission code: 25/30.05.2013). Written informed consent was received from all parents/ guardians of participating children.
Inclusion criteria were as follows: pediatric patients aged from one to 60 months treated as inpatients for LRTI at the Department of Pediatrics, Children's Clinical University Hospital in Rîga, Latvia. In accordance with Roth et al. (2008) , diagnosis of LRTI was defined as having at least one of the following clinical signs: fast or difficult breathing, chest wall indrawing, and abnormal auscultatory findings (crackles/crepitations or bronchial breath sounds). Fast breathing was defined in accordance with World Health Organization (WHO) criteria (Anonymous, 1995) . All patients had a fever (> 37.5°C) at the time of NPA sampling. Patient' clinical status was evaluated by a physician and only patients presenting with symptoms typical for viral infection were included in the study cohort. Children presenting with symptoms more than ten days of acute illness as well as those with severe chronic underlying illnesses were excluded.
In total, 90 children (60% male and 40% female), median age 23 months (range from two to 59 months) with LRTI during the period from October 2013 to December 2016 were included in this study. NPA were collected on admission and transported to the Institute of Microbiology and Virology, Rîga Stradiòð University, for virological examination.
In order to assess the prevalence rate of viral co-infections among different age groups, patients were divided into three groups. 1 st group: 0-11 months (n = 14; 7 male, 7 female), 2 nd group: 12-23 months (n = 33; 17 male, 16 female) and 3 rd group: 24-60 months (n = 43; male 30, female 13).
Laboratory methods. Total DNA was extracted from NPAs using standard phenol-chloroform extraction method.
Quantity of extracted DNA was tested spectrophotometrically and quality checked by determining the presence of a b-globin gene sequence by polymerase chain reaction (PCR).
We tested for the presence of 19 respiratory viruses in DNA samples using commercially available multiplex real-time PCR kits ( To confirm the presence of HBoV1 in HBoV positive DNA samples, PCR using primers specific to the HBoV1 NS1 gene sequence was performed in accordance with Sloots et al., 2006 . PCR products were analysed electrophoretically in 1.7% agarose gel with the expected PCR product size of 300 bp.
Data analysis. Sowtware GraphPad Prism 7 and Software
Excel 2016 were used for statistical analysis and data visualisation. The Fisher's exact test and unpaired t test were performed to estimate the differences and Spearman's correlation to test for significant relationships. A p value < 0.05 was considered statistically significant.
RESULTS

Distribution of respiratory viruses among different age groups. Presence of respiratory viruses as mono-infections
(defined as identification of a single viral pathogen in one sample) as well as co-infections (defined as identification of more than one viral pathogen in the same sample) in NPA samples of children with LRTI is summarised in Table 1 . Co-infection of more than one respiratory virus was detected more often than mono-infection. As it is seen in Fig-ure 1, there were cases in each age group where none of the respiratory viruses were detected (in the 1 st (0-11 months) and 2 nd (12-23 months) group -one case in each group and in the 3 rd (24-60 months) group -two cases). The number of viruses detected simultaneously among age groups (ranging from 1 to 6 viruses) is shown in Figure 1 .
For all age groups, DNA samples that were HBoV positive by multiplex PCR were also positive for HBoV1 specific PCR, showing that HBoV1 is present in respiratory specimens of children with LRTI in Latvia.
In total, the HBoV1 genomic sequence was detected in 60.0% of DNA samples extracted from NPA. In all three age groups HBoV1 was the most frequently detected virus. HBoV1 positivity (proportional as %) significantly differed between the 1 st and 2 nd age groups (p = 0.0159) and between the 1 st and 3 rd age groups (p = 0.0028) (Fig. 2 ).
HBoV1 and co-infections. In the 1 st age group the most common co-infections detected together with HBoV1 were HRV and RSV A (two cases of each virus) followed by HEV, MPV, AdV, RSV B, FluA H1, FluA H3, and FluB (one case of each virus). In the 2 nd age group the most frequently detected co-infections with HBoV1 were HRV (eight cases), followed by RSV A (six cases), AdV (four cases), PIV 3, and coronavirus OC43 (two cases each), HEV and FluB (one case). In the 3 rd group the frequency of co-infections with HBoV1 was as follows: AdV (12 cases), HRV and RSV B (eight cases each), RSV A (six cases), HEV (three cases), MPV and PIV 2 (each -two cases), PIV 1, PIV 3, coronaviruses 229E, OC43 and pdm09 (one case each). There was no statistically significant correlation between HBoV and any of the co-infections among age groups (data not shown). Numbers of viruses detected in co-infection with HBoV1 are represented in Figure 3 . HBoV1 infection simultaneously with one respiratory virus was the most frequent combination in the study group. LRTI, lower respiratory tract infection; N, number of patients eral publications have already described high sensitivity and specifity of multiplex PCR in detection of single or multiple respiratory viruses and can also be used to distinguish between acute viral and bacterial infection, thereby increasing the chance of reducing the use of unnecessarry antibiotics in treatment (Krause et al., 2014; Ljubin-Sternak et al., 2016; Bhuiyan et al., 2018) .
Mono-infection. HBoV1 mono-infection was revealed in
In the last years, molecular diagnostics have become more accessible in hospitals worldwide and in Latvia. Since 2012, HBoV1 testing is conducted routinely in the Children's Clinical University Hospital in Rîga. However, since HBoV1 can be detected in the respiratory tract even several months after infection, interpretation of causal agent becomes difficult in cases of co-infection. In the case of HBoV1 mono-infection accompanied by clinical symptoms characteristic of virus infection, it is clear that this virus is the responsible pathogen. However practitioners in Latvia are not well informed regarding the pathogenic properties of HBoV1 and often the result of the presence of this virus is not perceived with the severity it deserves. This is the first study in Latvia showing the presence of HBoV1 as monoinfection as well as co-infection with other respiratory viruses, has given new insights in the role of HBoV1 in causing diseases.
In this study HBoV1 was the most commonly detected respiratory virus in all age groups, reaching 65.12% positivity in the group aged from 24 to 60 months, 60.61% in the group from 12 to 23 months and 42.86% positivity in group aged from 0 to 11 months. HBoV1 was detected significantly more often in patients from the 2 nd and 3 rd groups, in comparison with patients from the 1 st group (p = 0.0159 and p = 0.0028). This finding coincides with results from other studies, where HBoV1 was more frequent in patients aged from six months up to five years of age (Arnold et al., 2006; Kesebir et al., 2006; Manning et al., 2006; Fry et al., 2007) . Most likely, HBoV1 seropositivity derived from mothers via vertical antibody transfer protects infants from infection with HBoV1 during the first few months of life (Endo et al., 2007; Kahn et al., 2008) . In the present study only one case of HBoV1 was detected in NPA of child younger than six months. It has been shown that the lowest HBoV1 IgG antibody detection rate occurs in children from six to 24 months of age. After this period, HBoV1 seropositivity increases and at the age of five years~90% of children have circulating antibodies against HBoV1 (Endo et al., 2007; Wang et al., 2010; Kantola et al., 2015) .
In the present study HBoV1 positivity was at least three times higher (60%) than the average HBoV1 prevalence globally, which ranges from 2 to 20% (Qiu et al., 2017) . The relatively high HBoV1 positivity in our study can be explained by selecting patients not older than 60 months and presenting symptoms typical for viral infection. Also in most of the studies, HBoV1 was detected using nested or real-time PCR methods that are often less sensitive than the multiplex real-time PCR used in the present study. On the other hand, some studies have reported a high HBoV1 detection rate. In a study conducted in the United States of America, HBoV1 positivity reached 59% in respiratory samples from symptomatic as well as asymptomatic children (Martin et al., 2010) , while in a study carried out in Canada, HBoV1 positivity among asymptomatic children was 43% (Longtin et al., 2008) showing relatively high HBoV1prevalence among the children population not only in Latvia.
Several studies showed that HBoV1 mono-infection is rare and that the co-infection rate among HBoV1 positive cases is up to 90%, which raises a question of whether HBoV1 is a true pathogen or a bystander (Fry et al., 2007; Christensen et al., 2008; Miron et al., 2010) . To better understand whether HBoV1 is a causative agent of the disease, it would be necessary to determine the presence of HBoV1-specific IgM class antibodies, thus indicatin acute infection. In this study HBoV1 mono-infection is revealed in 6.67% of all HBoV1 positive cases. In the present study, the most commonly detected co-infections with HBoV1 were HRV (37.50%), AdV (35.42%), RSV A (29.17%), RSV B (20.83%), MPV (10.42%) and HEV (10.42%). Our findings of co-infections are in line with results obtained by other research groups. For example, a group from China reported that RSV and HRV were the most frequently detected co-infections with HBoV1 (Sun et al., 2018) . Also in other studies, RSV, HRV, AdV, MPV, and HEV are mentioned as the most common co-infections with HBoV1 (Wang et al., 2010; Calvo et al., 2016; Liu et al., 2018) .
In the present study HBoV1 infection was not related to the duration of hospitalisation and did not cause specific clinical symptoms, but one patient from the study cohort with HBoV1 mono-infection had severe LRTI. This case was described in a case report (submitted for publication in the Journal of Medical Case Reports). There have been reports of more severe clinical manifestations in HBoV1 positive patients in comparison with those without HBoV1 infection. In a research carried out in Japan, hypoxia and neutrophilia were more severe in HBoV1-positive than in RSV-positive children with LRTI (Moriyama et al., 2010) . Several case reports described HBoV1-induced clinical features, including respiratory tract diseases as well as myocarditis, lung and colorectal tumours (Jula et al., 2013; Schildgen et al., 2013; Brebion et al., 2014) suggesting HBoV1 as a true pathogen in a wide range of diseases. Furthermore, in several studies HBoV1 has been detected in cerebrospinal fluid samples of patients with encephalitis, showing its ability to cross the blood-brain barrier and enter the central nervous system (Mitui et al., 2012; Mori et al., 2013; Yu et al., 2013) .
The results of the present study indicate that HBoV1 prevalence among children with LRTI is relatively high in Latvia and that HBoV1 infection is most frequently present in children aged from 12 to 60 months. Although HBoV1 mono-infection in case of LRTI is rare it should be treated as a serious pathogen when accompanied with clinical signs and symptoms. The most common co-infections with HBoV1 are HRV, AdV, RSV A, RSV B, MPV, and HEV.
